Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 357-379, 2003; 10.1373/49.3.357
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, A. H.B.
Right arrow Articles by Wax, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, A. H.B.
Right arrow Articles by Wax, P.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2003;49:357-379.)
© 2003 American Association for Clinical Chemistry, Inc.


Special Report

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Recommendations for the Use of Laboratory Tests to Support Poisoned Patients Who Present to the Emergency Department

Alan H.B. Wu1a, Charles McKay2, Larry A. Broussard3, Robert S. Hoffman4, Tai C. Kwong5, Thomas P. Moyer6, Edward M. Otten7, Shirley L. Welch8 and Paul Wax9

1 Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT 06102.

2 Department of Emergency Medicine, Medical Toxicology, Hartford Hospital, Hartford, CT 06102.

3 Department of Clinical Laboratory Sciences, Louisiana State University Health Sciences Center, New Orleans, LA 70112.

4 Department of Emergency Medicine, Bellevue Hospital Center, New York, NY 10016.

5 Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642.

6 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.

7 Department of Emergency Medicine, University of Cincinnati Hospital, Cincinnati, OH 45267.

8 Department of Pathology, Kaiser Permanente Regional Laboratory, Clackamas, OR 97015.

9 Department of Medical Toxicology Good Samaritan Regional Medical Center, Phoenix, AZ 85006

aCommittee Chairman. Address for correspondence: Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT 06102.

Background: Exposure to drugs and toxins is a major cause for patients’ visits to the emergency department (ED).

Methods: Recommendations for the use of clinical laboratory tests were prepared by an expert panel of analytical toxicologists and ED physicians specializing in clinical toxicology. These recommendations were posted on the world wide web and presented in open forum at several clinical chemistry and clinical toxicology meetings.

Results: A menu of important stat serum and urine toxicology tests was prepared for clinical laboratories who provide clinical toxicology services. For drugs-of-abuse intoxication, most ED physicians do not rely on results of urine drug testing for emergent management decisions. This is in part because immunoassays, although rapid, have limitations in sensitivity and specificity and chromatographic assays, which are more definitive, are more labor-intensive. Ethyl alcohol is widely tested in the ED, and breath testing is a convenient procedure. Determinations made within the ED, however, require oversight by the clinical laboratory. Testing for toxic alcohols is needed, but rapid commercial assays are not available. The laboratory must provide stat assays for acetaminophen, salicylates, co-oximetry, cholinesterase, iron, and some therapeutic drugs, such as lithium and digoxin. Exposure to other heavy metals requires laboratory support for specimen collection but not for emergent testing.

Conclusions:Improvements are needed for immunoassays, particularly for amphetamines, benzodiazepines, opioids, and tricyclic antidepressants. Assays for new drugs of abuse must also be developed to meet changing abuse patterns. As no clinical laboratory can provide services to meet all needs, the National Academy of Clinical Biochemistry Committee recommends establishment of regional centers for specialized toxicology testing.




The following articles in journals at HighWire Press have cited this article:


Home page
Journal of the American Animal Hospital AssociationHome page
J. B. Teitler
Evaluation of a Human On-site Urine Multidrug Test for Emergency Use With Dogs
J. Am. Anim. Hosp. Assoc., March 1, 2009; 45(2): 59 - 66.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. C. Drees, J. A. Stone, K. R. Olson, K. H. Meier, A. M. Gelb, and A. H. B. Wu
Clinical Utility of an LC-MS/MS Seizure Panel for Common Drugs Involved in Drug-Induced Seizures
Clin. Chem., January 1, 2009; 55(1): 126 - 133.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
G. M. Reisfield, E. Salazar, and R. L. Bertholf
Rational Use and Interpretation of Urine Drug Testing in Chronic Opioid Therapy
Ann. Clin. Lab. Sci., January 1, 2007; 37(4): 301 - 314.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M.-A. von Mach, L. S. Weilemann, and P. von Landenberg
Pseudocholinesterase Activity in Organophosphate Poisoning after Storage of Unseparated Blood Samples at Room Temperature for 3 Weeks
Clin. Chem., October 1, 2005; 51(10): 1907 - 1908.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
E M. Caravati, J. M Juenke, B. I Crouch, and K. T Anderson
Quetiapine Cross-Reactivity with Plasma Tricyclic Antidepressant Immunoassays
Ann. Pharmacother., September 1, 2005; 39(9): 1446 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S L Greene, P I Dargan, and A L Jones
Acute poisoning: understanding 90% of cases in a nutshell
Postgrad. Med. J., April 1, 2005; 81(954): 204 - 216.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C. Dale, A.A.M. Aulaqi, J. Baker, R.C. Hobbs, M.E.L. Tan, C. Tovey, I.A.L. Walker, and J.A. Henry
Assessment of a point-of-care test for paracetamol and salicylate in blood
QJM, February 1, 2005; 98(2): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. W. Boyer and M. W. Shannon
Which Drug Tests in Medical Emergencies?
Clin. Chem., March 1, 2003; 49(3): 353 - 354.
[Full Text] [PDF]

eLetters:

Read all eLetters

agree or not agree :this is a question
ruggeri saverio, et al.
Clinical Chemistry Online, 12 May 2003 [Full text]
Guidelines: make scope as explicit as possible
Joseph C. Watine
Clinical Chemistry Online, 16 Sep 2003 [Full text]
Re: Guidelines: make scope as explicit as possible
Alan H Wu, et al.
Clinical Chemistry Online, 29 Sep 2003 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.